Remove 2007 Remove Documentation Remove Packaging
article thumbnail

PDA revises report on glass container manufacturing

European Pharmaceutical Review

The long-awaited PDA TR 43 report provides an approach to a quality decision-making process and represents best practices for the identification and classification of visual nonconformities for (empty) glass containers as pharmaceutical product packaging.

article thumbnail

CMS Proposals Would Raise the Bar on Bona Fide Service Fees for Average Sales Price

FDA Law Blog: Biosimilars

This definition is familiar to drug manufacturers because it is substantially identical to the definition that has existed under the MDRP since 2007. The manufacturer’s documentation of the methodology used to determine fair market value would have to be submitted, along with other reasonable assumptions, to CMS each quarter.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Air Quality and Hashimoto’s – Is the Air You’re Breathing Making You Sick?

The Thyroid Pharmacist

Feel free to use my own health timeline as a guideline to document your health journey. Most filter manufacturers have pictures on their filter packaging that indicate what they will and will not filter, along with the MERV rating. 2007-00313. 2007; 41(6) 1230-1236. Invest in a High-Quality Portable Air Filter.

article thumbnail

High-Dose Insulin Euglycemic Therapy in Calcium Channel Blocker and Beta-Blocker Toxicity

Pharmacy Friday Pearls

2007 Prospective observational review (n=7) 50 mL of 50% IV dextrose was followed by a loading dose (1 unit/kg) of IV short-acting insulin and a insulin maintenance infusion (0.52.0 mmol/L) There was no documented blood glucose concentration <100 mg/dL recording during the first 12 hrs of HIET. Greene et al., High-dose insulin.,